Barclays’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $729K | Sell |
645,325
-10,066
| -2% | -$11.4K | ﹤0.01% | 2839 |
|
|
2025
Q1 | $958K | Sell |
655,391
-105,895
| -14% | -$155K | ﹤0.01% | 2473 |
|
|
2024
Q4 | $1.62M | Buy |
761,286
+418,313
| +122% | +$891K | ﹤0.01% | 2346 |
|
|
2024
Q3 | $959K | Buy |
342,973
+172,745
| +101% | +$483K | ﹤0.01% | 2640 |
|
|
2024
Q2 | $396K | Buy |
170,228
+13,481
| +9% | +$31.4K | ﹤0.01% | 2672 |
|
|
2024
Q1 | $700K | Sell |
156,747
-28,160
| -15% | -$126K | ﹤0.01% | 2633 |
|
|
2023
Q4 | $594K | Sell |
184,907
-601,886
| -76% | -$1.93M | ﹤0.01% | 2908 |
|
|
2023
Q3 | $2.5M | Buy |
786,793
+117,596
| +18% | +$373K | ﹤0.01% | 1529 |
|
|
2023
Q2 | $3.33M | Buy |
669,197
+168,546
| +34% | +$838K | ﹤0.01% | 1454 |
|
|
2023
Q1 | $2.47M | Buy |
500,651
+77,598
| +18% | +$383K | ﹤0.01% | 1513 |
|
|
2022
Q4 | $2.66M | Buy |
423,053
+105,287
| +33% | +$662K | ﹤0.01% | 1466 |
|
|
2022
Q3 | $3.43M | Buy |
317,766
+287,087
| +936% | +$3.1M | ﹤0.01% | 1314 |
|
|
2022
Q2 | $350K | Sell |
30,679
-73,692
| -71% | -$841K | ﹤0.01% | 2807 |
|
|
2022
Q1 | $951K | Buy |
104,371
+4,039
| +4% | +$36.8K | ﹤0.01% | 2357 |
|
|
2021
Q4 | $1.5M | Buy |
100,332
+56,582
| +129% | +$844K | ﹤0.01% | 1961 |
|
|
2021
Q3 | $1.12M | Sell |
43,750
-52,184
| -54% | -$1.34M | ﹤0.01% | 2191 |
|
|
2021
Q2 | $2.5M | Sell |
95,934
-33,584
| -26% | -$876K | ﹤0.01% | 1591 |
|
|
2021
Q1 | $4.57M | Buy |
129,518
+68,113
| +111% | +$2.4M | ﹤0.01% | 1255 |
|
|
2020
Q4 | $1.55M | Sell |
61,405
-17,899
| -23% | -$452K | ﹤0.01% | 1732 |
|
|
2020
Q3 | $2.99M | Sell |
79,304
-9,307
| -11% | -$351K | ﹤0.01% | 1249 |
|
|
2020
Q2 | $3.8M | Buy |
88,611
+26,629
| +43% | +$1.14M | ﹤0.01% | 1070 |
|
|
2020
Q1 | $1.2M | Buy |
61,982
+13,896
| +29% | +$270K | ﹤0.01% | 1610 |
|
|
2019
Q4 | $1.25M | Buy |
48,086
+16,197
| +51% | +$420K | ﹤0.01% | 2170 |
|
|
2019
Q3 | $870K | Buy |
31,889
+6,883
| +28% | +$188K | ﹤0.01% | 2338 |
|
|
2019
Q2 | $671K | Sell |
25,006
-5,005
| -17% | -$134K | ﹤0.01% | 2575 |
|
|
2019
Q1 | $868K | Buy |
30,011
+29,027
| +2,950% | +$840K | ﹤0.01% | 2250 |
|
|
2018
Q4 | $27K | Buy |
+984
| New | +$27K | ﹤0.01% | 3313 |
|